Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) shares rose 14.6% on Thursday . The company traded as high as $4.12 and last traded at $4.12. Approximately 1,525 shares changed hands during trading, a decline of 97% from the average session volume of 57,925 shares. The stock had previously closed at $3.5960.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold”.
View Our Latest Analysis on Raia Drogasil
Raia Drogasil Price Performance
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
- Five stocks we like better than Raia Drogasil
- Alphabet Crushed Earnings, But One Number Spooked the Market
- Otis Took Another Guidance Cut—But the Story Isn’t Over
- Is Buying a Launch Company AST SpaceMobile’s Next Vertical Integration Move?
- AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
